Patent Assignment
Reel/Frame 054921/0863
Assignment of Assignor's Interest
Recorded: 2021-01-14
Pages: 17
Assignor
MILLENNIUM PHARMACEUTICALS, INC.
Executed: 2020-02-03
Assignee
DOT THERAPEUTICS-1, INC.
2765 SAND HILL ROAD, MENLO PARK, CALIFORNIA, 94025
Covered Property
(1)
Compounds Useful as Raf Kinase Inhibitors
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 8, 2021
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 055524/0173 →
Assignment of Assignor's Interest
Mar 8, 2021
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 055524/0371 →
Assignment of Assignor's Interest
Mar 8, 2021
From: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
To: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 055524/0457 →
Assignment of Assignor's Interest
Mar 8, 2021
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 055524/0525 →
Merger
May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Change of Name
Apr 14, 2023
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 063349/0100 →
Assignment of Assignor's Interest
Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest
Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →